Table 1 Characteristics of included patients between intervention and control group.
Variable | Bupivacaine (N = 22) | Placebo (N = 19) |
|---|---|---|
Age in years, mean (SD) | 47 (15) | 47 (12) |
Sex, (% (N) female) | 77.3 (17) | 94.7 (18) |
Body-mass-index, mean (SD) kg m−2 | 27.9 (6.7) | 28.6 (6.9) |
Diabetes (% (N) yes) | 4.5 (1) | 5.3 (1) |
Smoking (% (N) yes) | 28.6 (6) | 26.3 (5) |
Preoperative opioids (% (N) yes) | 36.4 (8) | 36.8 (7) |
Oral anticoagulation (% (N) yes) | 22.7 (5) | 10.5 (2) |
ASA classification (% (N)) | ||
I | 9.1 (2) | 10.5 (2) |
II | 63.6 (14) | 73.7 (14) |
III | 27.3 (6) | 15.8 (3) |
Causes of SIJ dysfunction (% (N)) | ||
Postpartum | 36.4 (8) | 47.4 (9) |
Ehlers Danlos syndrome | 27.3 (6) | 26.3 (5) |
Prior lumbar fusion surgery | 9.1 (2) | 10.5 (2) |
Posttraumatic | 4.5 (1) | 10.5 (2) |
Other | 22.7 (5) | 5.3 (1) |
Side (% (N), right) | 68.2 (15) | 47.4 (9) |